• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: May 18 - 24, 2014

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

Official Name: Margaret A. Hamburg, M.D., Commissioner of Food and Drugs

Event Date: 05/18/2014 – 05/22/2014
Location: Geneva, Switzerland
Subject: World Health Assembly
FDA Participant/Group: Katherine Bond; Mary Lou Valdez
Non FDA Participant/Group: N/A

Official Name: Elizabeth H. Dickson, Esq., Chief Counsel

No Significant Event

Official Name: Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine

Event Date: 05/21/2014
Location: Rockville, MD
Subject: Meet and Greet
FDA Participant/Group: Eric Dubbin; Roxanne Schweitzer; Tracey Forfa; Daniel McChesney; William Flynn; Janis Messenheimer; Jeffrey Ward
Non FDA Participant/Group: N/A

Official Name: Walter S. Harris, M.B.A., P.M.P., Deputy Commissioner for Operations and Chief Operating Officer

Event Date: 05/23/2014
Location: Teleconference
Subject: Discuss Cybersecurity
FDA Participant/Group: Alan McClelland
Non FDA Participant/Group: JH Lute; Maurice; Uenuma; Tony Sager (Council on Cybersecurity)

Official Name: Sally Howard, J.D., Deputy Commissioner for Policy, Planning and Legislation

No Significant Event

Official Name: Steven Immergut, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: Michael M. Landa, Director, Center for Food Safety and Applied Nutrition

Event Date: 05/20/2014 - 05/22/2014
Location: Dauphin Island, AL
Subject: Site Visit to Dauphin Island, Alabama
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Peter Lurie, M.D., M.P.H., Acting Associate Commissioner for Policy and Planning

No Significant Event

Official Name: Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research

Event Date: 05/21/2014
Location: Washington, D.C.
Subject: President's Council of Advisors on Science and Technology and 21st Century Cures
FDA Participant/Group: N/A
Non FDA Participant/Group: Representative Joe Pitts (R-TX)

Official Name: Stephen M. Ostroff, M.D., Acting Chief Scientist

No Significant Event

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 05/21/2014
Location: Silver Spring, MD
Subject: Regulatory Science
FDA Participant/Group: Michelle McMurry-Heath
Non FDA Participant/Group: Michael Ringel, Ph.D.

Official Name: Howard Sklamberg, J.D., Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Michael R. Taylor, J.D., Deputy Commissioner for Foods and Veterinary Medicine

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

Event Date: 05/18/2014 – 05/22/2014
Location: Geneva, Switzerland
Subject: World Health Assembly
FDA Participant/Group: Katherine Bond; Margaret A. Hamburg
Non FDA Participant/Group: N/A

Official Name: Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date: 05/19/2014 - 05/20/2014
Location: London, UK
Subject: Hever 19
FDA Participant/Group: N/A
Non FDA Participant/Group: Elias Zerhouni

Event Date: 05/20/2014
Location: Boston, MA
Subject: MIT CBI Visit
FDA Participant/Group: N/A
Non FDA Participant/Group: Stacy Hirsch, Gigi Leung, Jim Springs,

Event Date: 05/20/2014
Location: Boston, MA
Subject: International Symposium on Continuous Manufacturing of Pharmaceuticals
FDA Participant/Group: N/A
Non FDA Participant/Group: Nasr, Moheb

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event